| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 01/10/2013 | US20130012532 Cyclopropanecarboxylic acid derivative |
| 01/10/2013 | US20130012530 New Positive allosteric modulators of nicotinic acetylcholine receptor |
| 01/10/2013 | US20130012521 Apoptosis signal-regulating kinase inhibitors |
| 01/10/2013 | US20130012517 Quinoline and Quinoxaline Derivatives as Kinase Inhibitors |
| 01/10/2013 | US20130012515 Fused Bicyclic Pyridine and Pyrazine Derivatives as Kinase Inhibitors |
| 01/10/2013 | US20130012511 Soluble guanylate cyclase activators |
| 01/10/2013 | US20130012510 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1 and cx3cr1 |
| 01/10/2013 | US20130012505 Benzonaphthyridinamines as autotaxin inhibitors |
| 01/10/2013 | US20130012498 5ht2c receptor modulators |
| 01/10/2013 | US20130012495 5ht2c receptor modulators |
| 01/10/2013 | US20130012494 Cyclopropyl-fused-1,3-thiazepines as bace1 and/or bace2 inhibitors |
| 01/10/2013 | US20130012493 Novel spiro imidazolone derivatives as glucagon receptor antagonists, compositions, and methods for their use |
| 01/10/2013 | US20130012486 Combination steroid and glucocorticoid receptor antagonist therapy |
| 01/10/2013 | US20130012485 Organic compounds |
| 01/10/2013 | US20130012479 Polymorphs of 6-(piperidin-4-yloxy)-2h-isoquinolin-1-one hydrochloride |
| 01/10/2013 | US20130012478 Dosage forms of bisphosphonates |
| 01/10/2013 | US20130012466 Colchicine neoglycosides and methods for their synthesis and use |
| 01/10/2013 | US20130012458 7-hydroxy chromones as potent antioxidants |
| 01/10/2013 | US20130012434 Novel spiro imidazolones as glucagon receptor antagonists, compositions, and methods for their use |
| 01/10/2013 | US20130012433 Method for reducing cardiovascular morbidity and mortality in prediaetic patients and patients with type 2 diabetes |
| 01/10/2013 | US20130012432 Peptides for Treatment of Obesity |
| 01/10/2013 | US20130012431 Method For Elevating Prolactin In Mammals |
| 01/10/2013 | US20130012427 Polypeptides |
| 01/10/2013 | US20130011500 Ginger Extract for Inhibiting the Fat-storage Function of Adipocytes and a Medication thereof |
| 01/10/2013 | US20130011498 Method of using beta-hydroxy-beta-methylbutyrate for reducing tumor growth rate |
| 01/10/2013 | US20130011478 Pharmacologically optimized multimodal drug delivery system for nordihydroguiaretic acid (ndga) |
| 01/10/2013 | US20130011472 Stable pharmaceutical composition and methods of using same |
| 01/10/2013 | US20130011471 Stable pharmaceutical composition and methods of using same |
| 01/10/2013 | US20130011444 Compositions and methods for overcoming resistance to tramadol |
| 01/10/2013 | US20130011412 Antibodies to lymphotoxin-alpha |
| 01/10/2013 | US20130011405 Antagonist anti-cd40 monoclonal antibodies and methods for their use |
| 01/10/2013 | US20130011398 Serpin Fusion Polypeptides and Methods of Use Thereof |
| 01/10/2013 | US20130011391 Anti-psgl-1 antibodies and uses thereof |
| 01/10/2013 | US20130011379 Pyridoxamine for the Treatment of Diabetic Kidney Disease |
| 01/10/2013 | US20130011378 Stable formulations of a hyaluronan-degrading enzyme |
| 01/10/2013 | US20130011377 Compositions, kits and methods for nutrition supplementation |
| 01/10/2013 | US20130011361 Pyrazole derivatives which modulate stearoyl-coa desaturase |
| 01/10/2013 | CA2843853A1 Macrocyclic insulin-degrading enzyme (ide) inhibitors and uses thereof |
| 01/10/2013 | CA2840985A1 Anti-obesity agent comprising high-purity epa |
| 01/10/2013 | CA2838309A1 Oligosaccharides composition for preventing or reducing the risk of metabolic syndrome |
| 01/10/2013 | CA2835607A1 Compositions, uses and methods for treatment of metabolic disorders and diseases |
| 01/09/2013 | EP2543660A1 Prophylactic or therapeutic agent for diabetes or obesity |
| 01/09/2013 | EP2543379A1 Novel lactobacillus strain, composition and use thereof for improving the syndrome of diabetes and complication thereof |
| 01/09/2013 | EP2542687A1 Involvement of androgen/androgen receptor pathway in fabry disease |
| 01/09/2013 | EP2542060A1 Compositions and methods for treating and/or preventing cardiovascular disease |
| 01/09/2013 | CN102869669A Heterocycloalkyl-containing thienopyrimidines for pharmaceutical compositions |
| 01/09/2013 | CN102869667A Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation |
| 01/09/2013 | CN102869665A Benzazepine compound |
| 01/09/2013 | CN102869658A Modulators of fatty acid amide hydrolase |
| 01/09/2013 | CN102869656A Tetrahydrobenzothiophene compound |
| 01/09/2013 | CN102869382A Composition for inhibiting hyperlipidemia and obesity by inhibiting intestinal absorption of cholesterol |
| 01/09/2013 | CN102863901A Method for extracting coreopsis tinctoria oil resin by using supercritical or subcritical CO2 |
| 01/09/2013 | CN102863532A Interferon alpha receptor 1 antibodies and their uses |
| 01/09/2013 | CN102863440A Crystallographic form of salt of dipeptidyl peptidase-IV inhibitor |
| 01/09/2013 | CN102863436A Thiazolidinedione derivatives, preparation thereof and use thereof |
| 01/09/2013 | CN102863432A Modulators of cftr |
| 01/09/2013 | CN102863417A C-indican derivative |
| 01/09/2013 | CN102863362A Aryl compounds as ppar ligands and their use |
| 01/09/2013 | CN102863338A Compound and medical use thereof |
| 01/09/2013 | CN102861360A Neural restoration promoting material as well as preparation method and application thereof |
| 01/09/2013 | CN102861340A Intelligent nano delivery system, preparation method and application thereof |
| 01/09/2013 | CN102861336A Parenteral nutrition composition containing iron |
| 01/09/2013 | CN102861335A DHEA compositions for treating menopause |
| 01/09/2013 | CN102861309A Preparation method of composition consisting of herba agrimoniae and rhizoma zingiberis |
| 01/09/2013 | CN102861289A Chinese medicinal drug addiction stopping and three-hyper lowering capsule |
| 01/09/2013 | CN102861287A Chinese medicinal composition for treating damp-heat invasion blood stasis diabetic foot and preparation method thereof |
| 01/09/2013 | CN102861280A Traditional Chinese medicine for treating diabetes mellitus |
| 01/09/2013 | CN102861278A Lipid-lowering extract from effective parts of sharpleaf galangal fruit and preparation and application thereof |
| 01/09/2013 | CN102861263A Blood glucose reducing preparation made of pure traditional Chinese medicines |
| 01/09/2013 | CN102861256A Method for preparing flavone from bamboo leaves |
| 01/09/2013 | CN102861240A Traditional Chinese medicine formula for treating diabetes mellitus |
| 01/09/2013 | CN102861234A Traditional Chinese medicine for enhancing pancreatic functions |
| 01/09/2013 | CN102861229A Medicine for treating diabetes |
| 01/09/2013 | CN102861224A Oyster lipid-lowering capsule and preparation method |
| 01/09/2013 | CN102861223A Seven-medicament diabetes treating capsule |
| 01/09/2013 | CN102861201A Medicine composition for treating diabetes and preparation method thereof |
| 01/09/2013 | CN102861192A Medicine composition for chronic renal failure and peritoneal fibrosis |
| 01/09/2013 | CN102861187A Weight-reducing aid |
| 01/09/2013 | CN102861186A Medicine for improving bioavailability of atorvastatin |
| 01/09/2013 | CN102861135A Extraction method of buckwheat flavonoids |
| 01/09/2013 | CN102861123A Traditional Chinese medicine extract with effect on promoting angiogenesis as well as preparation method and application thereof |
| 01/09/2013 | CN102861114A Kiwi fruit extract and extraction method and application thereof |
| 01/09/2013 | CN102861023A Application of saringosterol |
| 01/09/2013 | CN102861013A Pharmaceutical composition and preparation of 17 amino acids |
| 01/09/2013 | CN102861012A Medicine composition containing 18 amino acids and preparation thereof |
| 01/09/2013 | CN102861011A Medicine composition of 18 amino acids and preparation |
| 01/09/2013 | CN102861004A Use of a fatty acid composition comprising at least one of epa and dha or any combinations thereof |
| 01/09/2013 | CN102861002A Application and determining method of zinc ion as alpha-glucosidase inhibitor |
| 01/09/2013 | CN102860996A Method for preparing lycoypene microcapsule |
| 01/09/2013 | CN102860994A Rosuvastatin calcium tablet and preparation method |
| 01/09/2013 | CN102860520A Novel nutraceutical compositions |
| 01/09/2013 | CN102860429A Concentrated feed for small tailed han sheep and method for preparing same |
| 01/09/2013 | CN102860396A Lipid-lowering decompression tea |
| 01/09/2013 | CN102860390A Mulberry leaf weight-reducing tea and method for preparing same |
| 01/09/2013 | CN102343100B Method for quickly preparing rutin inclusion compound |
| 01/09/2013 | CN102273636B Natural organic sea buckthorn fruit acid and processing method thereof |
| 01/09/2013 | CN102138946B Birch bark extractive as well as preparation method and medical purposes thereof |
| 01/09/2013 | CN102138945B Method of extracting active substances with high content of flavones from ginkgo leaves |
| 01/09/2013 | CN102048701B Pitavastatin calcium enteric sustained-release micropill preparation and preparation method thereof |
| 01/09/2013 | CN101991127B Powdery mixture containing phytosterol and oryzanol and preparation method thereof |